According to Fortune Business Insights, the global veterinary oncology market size was valued at USD 2.90 billion in 2025 and is projected to grow from USD 3.15 billion in 2026 to USD 7.11 billion by 2034, exhibiting a CAGR of 10.70% during the forecast period. North America dominated the veterinary oncology market with a market share of 47.58% in 2025.
The veterinary oncology market is gaining importance as pet ownership increases and companion animals receive more advanced medical care. Cancer is among the major health concerns affecting companion animals, particularly as pets live longer due to improvements in nutrition, preventive healthcare, diagnostics, and veterinary services. Greater awareness among pet owners regarding cancer symptoms and treatment options is encouraging earlier veterinary consultations and diagnosis. Veterinary clinics and specialty hospitals are increasingly adopting advanced diagnostic and therapeutic approaches to improve outcomes for animals affected by cancer. These developments include imaging technologies, biopsy procedures, histopathology, immunohistochemistry, chemotherapy, radiation therapy, targeted therapies, and surgical oncology. The veterinary oncology market is also benefiting from increasing expenditure on companion animal healthcare. Pet owners are increasingly willing to pursue specialized treatments and diagnostic procedures for their animals, particularly in developed markets. Veterinary hospitals are expanding oncology services, while pharmaceutical companies are developing therapies specifically designed for animal patients. Growing research into animal cancers is also improving understanding of tumor biology and supporting the development of new therapeutic approaches. Increasing collaboration between veterinary institutions, pharmaceutical companies, diagnostic laboratories, and research organizations is expected to strengthen the availability of specialized oncology care. The veterinary oncology market therefore represents an important segment of the broader animal healthcare industry, supported by advances in diagnosis, treatment, and veterinary clinical infrastructure.
Continue reading for more details:
https://www.fortunebusinessinsights.com/veterinary-oncology-market-117236
The veterinary oncology market is segmented by animal type, cancer type, treatment, distribution channel, and region. Based on animal type, the market includes dogs, cats, and other animals. Dogs represent a major segment because canine cancer is frequently diagnosed in veterinary practice and pet owners increasingly seek specialized treatment. Cats also represent an important segment as awareness of feline cancer and access to specialized veterinary services continue to improve.
Based on cancer type, the veterinary oncology market is categorized into lymphoma, mast cell tumors, mammary tumors, soft tissue sarcomas, osteosarcoma, and other cancers. Lymphoma represents a significant cancer category because it affects multiple animal species and can require specialized diagnostic and therapeutic management. Mast cell tumors are also important, particularly in dogs, creating demand for veterinary oncology diagnostics, surgery, and drug-based treatment.
By treatment, the market includes surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, and other treatment approaches. Surgery remains an important treatment option for localized tumors and is frequently used as part of comprehensive cancer management. Chemotherapy is widely utilized for cancers that require systemic treatment. Radiation therapy is gaining attention for managing tumors that cannot be completely removed through surgery. Immunotherapy and targeted therapy are emerging areas of veterinary oncology as researchers seek more precise treatment approaches with improved therapeutic outcomes.
Based on distribution channel, the veterinary oncology market is divided into veterinary hospitals and clinics, specialty veterinary centers, veterinary pharmacies, and other channels. Veterinary hospitals and clinics account for a significant share because diagnosis, treatment planning, surgery, chemotherapy, and follow-up care are generally delivered through veterinary healthcare facilities. Specialty veterinary centers are also becoming increasingly important as they provide access to veterinary oncologists, advanced diagnostic equipment, radiation therapy, and specialized treatment programs.